EU Commission clears acquisition of joint control of Infrareal by Gelsenwasser and Swiss Life

The European Commission has approved, under the EU Merger Regulation, the acquisition of joint control of Infrareal GmbH by Gelsenwasser AG, both of Germany, and Swiss Life Holding AG (‘Swiss Life’) of Switzerland.

Infrareal consists of two operational subsidiaries, Pharmaserv GmbH and Pharmapark Jena GmbH, which operate business parks in Germany with a focus on the life science sector and provide, inter alia, site management services, integrated infrastructure and technical and logistics services.

Gelsenwasser is a utilities company that supplies natural gas and fresh water to residents in Germany. It is mainly active in water, wastewater, energy networks, energy sales and investments. Swiss Life is a provider of comprehensive life, pensions and financial solutions. The Commission concluded that the proposed acquisition would raise no competition concerns given its limited impact on the market. The transaction was examined under the simplified merger review procedure. More information is available on the Commission’s competition website, in the public case register under the case number M.10446.